Asthmatics face a deadline of December 31, 2011 to switch from using epinephrine inhalers to other prescription treatment methods under an order from the Food and Drug Administration. At issue is the ...

Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjector costs will be capped at $25 and asthma inhaler costs will be capped at $50. These ...

TRENTON, N.J. (AP) — A new version of the once-popular asthma inhaler Primatene Mist will soon return to U.S. stores. The Food and Drug Administration approved the over-the-counter aerosol inhaler ...

WASHINGTON -- Asthma sufferers may not be able to buy non-prescription inhalers much longer because the devices contain propellants that harm the ozone layer. An advisory panel voted 11-7 on Tuesday ...

A law signed in 2023 caps out-of-pocket costs for insulin, asthma inhalers, and epinephrine injectors beginning Jan. 1. (Photo Illustration by Spencer Platt/Getty Images) Health insurance rules ...

Primatene Mist, the only over-the-counter asthma inhaler sold in the United States, will no longer be available after Dec. 31, 2011 because it uses chlorofluorcarbons (CFCs), a substance that depletes ...

WASHINGTON, Sept 20 (Reuters) - U.S. health officials on Thursday proposed phasing out the use of chlorofluorocarbons (CFCs) in metered-dose asthma inhalers that contain the drug epinephrine. The Food ...

WASHINGTON — Millions of nonprescription inhalers used for decades by asthma sufferers, often against the advice of doctors, could be taken off drugstore shelves because they contain propellants that ...

For at least the past month, Primatene Mist, the remedy of last resort for asthmatic New Yorkers–particularly for those without health insurance–has been all but impossible to obtain in the five ...

U.S. health care providers should begin issuing replacement prescriptions now for patients with asthma that use Primatene Mist (Armstrong Pharmaceuticals Inc.), the FDA advises. The only ...

WASHINGTON - Asthma sufferers may not be able to buy nonprescription inhalers much longer because the devices contain propellants that some think harm the ozone layer. An advisory panel voted 11-7 ...